- Dr Martens Plc
- 19 May 2026 11:15:54
Source: Sharecast
Adjusted pre-tax profit for the year to March 29 soared by 61% to £55m, driven by a "standout" 19% jump in shoe sales and beating analysts' estimates of £51m. Chief executive Ije Nwokorie has implemented a “consumer first” strategy, cutting back on discount activity and expanding product lines to boost margin recovery.
Revenue was down 2.9% in reported terms to £764.9m with direct-to-consumer revenue partly hit by the switch to full-price sales.
Full-price direct-to-consumer revenue in its largest market, the US, rose 14%, as Dr Martens cut its reliance on discounted sales to wholesale partners.
The company also revealed it had paid around £10m in US tariffs, which would be treated as an exceptional cost "due to their magnitude and unusual nature, with any future refunds to be considered exceptional income" after the Supreme Court ruled the levies illegal.
“We are currently navigating an unpredictable trading environment, with geopolitical uncertainty impacting consumer confidence, and against this backdrop are focused on executing our strategy,” the company said on Tuesday.
“There is still ongoing work to complete in some areas of the business, including the execution of our retail strategy, which will represent a short-term revenue headwind. However, our business is materially more resilient than it was previously, and this underpins our confidence in our medium-term targets.”
Dr Martens has also cut inventory and debt as part of its turnaround strategy after profits last year were hit by high costs and weak US wholesale demand, while American tariffs also added extra costs.
Reporting by Frank Prenesti for Sharecast.com